Press Release
BusinessHealthcare

Narcolepsy Market Insight, Epidemiology and Market Forecast 2028

It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market revenue, sales trends, and drug uptake during the study period from 2016-2028.

DelveInsight’s Narcolepsy Market Insights, Epidemiology and Market Forecast 2028” report provides a detailed overview of the disease and in-depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market revenue, sales trends, and drug uptake during the study period from 2016-2028.
Markets Covered

• United States

• EU5 (Germany, France, Italy, Spain and the United Kingdom)

• Japan
Study Period: 2016-2028

Narcolepsy Understanding and Treatment Algorithm
The Narcolepsy report provides an in-depth analysis of the disease overview by providing details such as disease definition, classification, symptoms, etiology, pathophysiology and diagnostic trends. The comprehensive details about treatment algorithms and treatment guidelines for Narcolepsy in the US, Europe, and Japan are also provided in the report.

Narcolepsy Epidemiology
This section provides insights about historical and current patient pool and forecasted trend for 7 major markets. It takes in to account the analysis of numerous studies, survey reports as well as KOL’s views which helps to recognize the factors behind the current and forecasted trends, diagnosed and treatable patient pool along with assumptions undertaken.

Narcolepsy Product Profiles & Analysis
This part of the Narcolepsy report encloses the detailed analysis of marketed drugs and Phase III and late Phase II pipeline drugs. It provides the key cross competition which evaluates the drugs on several parameters including, safety & efficacy results, mechanism of action, route, launch dates and designations. This section also covers the market intelligence and tracking of latest happenings, agreements and collaborations, approvals, patent details and other major breakthroughs.

Narcolepsy Market Outlook
The Narcolepsy market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the Narcolepsy market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. This segment analyzes the market trend of each marketed drug and late-stage pipeline drugs. This is done by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders . The calculated market data is presented with relevant tables and graphs to give a clear view of the market at first sight.
Narcolepsy Market Share by Therapies
This section focusses on the rate of uptake of the potential drugs recently launched or will be launched in the market during the study period from 2016-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug. This information also helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It provides a comparison of the drugs on the basis of market share and size. This analysis helps in investigating factors important in market uptake and in making financial as well as regulatory decisions.
Narcolepsy Report Insights

• Patient Population in Narcolepsy

• Therapeutic Approaches in Narcolepsy

• Narcolepsy Pipeline Analysis

• Narcolepsy Market Size and Trends

• Narcolepsy Market Opportunities

• Impact of upcoming Therapies in Narcolepsy
Narcolepsy Report Key Strengths

• 10 Year Forecast

• 7MM Coverage

• Epidemiology Segmentation

• Drugs Uptake

• Highly Analyzed Market

• Key Cross Competition

Request for sample pages

Narcolepsy Report Assessment

• Narcolepsy Current Treatment Practices

• Unmet Needs in Narcolepsy

• Detailed Narcolepsy Pipeline Product Profiles

• Market Attractiveness

• Market Drivers and Barriers

Key Benefits

• This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving the Narcolepsy market

• Organize sales and marketing efforts by identifying the best opportunities for Narcolepsy market

• To understand the future market competition in the Narcolepsy market.

Table of contents

1. Report Introduction
2. Narcolepsy Market Overview at a Glance
2.1. Market Share Distribution of Narcolepsy in 2017
2.2. Market Share Distribution of Narcolepsy in 2028
3. Narcolepsy Disease Background and Overview
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Narcolepsy Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Narcolepsy in 7MM
4.3. Total Prevalent Patient Population of Narcolepsy in 7MM– By Countries
5. Narcolepsy Epidemiology of Narcolepsy by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Narcolepsy
5.1.3. Sub-Type Specific cases of the Narcolepsy
5.1.4. Sex- Specific Cases of the Narcolepsy
5.1.5. Diagnosed Cases of the Narcolepsy
5.1.6. Treatable Cases of the Narcolepsy
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Narcolepsy
5.4.3. Sub-Type Specific cases of the Narcolepsy
5.4.4. Sex- Specific Cases of the Narcolepsy
5.4.5. Diagnosed Cases of the Narcolepsy
5.4.6. Treatable Cases of the Narcolepsy
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Narcolepsy
5.5.3. Sub-Type Specific cases of the Narcolepsy
5.5.4. Sex- Specific Cases of the Narcolepsy
5.5.5. Diagnosed Cases of the Narcolepsy
5.5.6. Treatable Cases of the Narcolepsy
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Narcolepsy
5.6.3. Sub-Type Specific cases of the Narcolepsy
5.6.4. Sex- Specific Cases of the Narcolepsy
5.6.5. Diagnosed Cases of the Narcolepsy
5.6.6. Treatable Cases of the Narcolepsy
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Narcolepsy
5.7.3. Sub-Type Specific cases of the Narcolepsy
5.7.4. Sex- Specific Cases of the Narcolepsy
5.7.5. Diagnosed Cases of the Narcolepsy
5.7.6. Treatable Cases of the Narcolepsy
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Narcolepsy
5.8.3. Sub-Type Specific cases of the Narcolepsy
5.8.4. Sex- Specific Cases of the Narcolepsy
5.8.5. Diagnosed Cases of the Narcolepsy
5.8.6. Treatable Cases of the Narcolepsy
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Narcolepsy
5.9.3. Sub-Type Specific cases of the Narcolepsy
5.9.4. Sex- Specific Cases of the Narcolepsy
5.9.5. Diagnosed Cases of the Narcolepsy
5.9.6. Treatable Cases of the Narcolepsy
6. Narcolepsy Current Treatment & Medical practices
6.1. Treatment Algorithm
6.2. Treatment Guidelines
7. Unmet Needs of the Narcolepsy
8. Narcolepsy Marketed Therapies
8.1. Drug A: Company 1
8.1.1. Drug Description
8.1.2. Mechanism of Action
8.1.3. Regulatory Milestones
8.1.4. Advantages & Disadvantages
8.1.5. Product Profile
8.2. Drug B: Company 2
8.2.1. Drug Description
8.2.2. Mechanism of Action
8.2.3. Regulatory Milestones
8.2.4. Advantages & Disadvantages
8.2.5. Product Profile
9. Pipeline Therapies– At a glance
10. Key Cross Competition
11. Narcolepsy Emerging Therapies
11.1. Drug C: Company 3
11.1.1. Drug Description
11.1.2. Clinical Trials Details
11.1.3. Safety and Efficacy Profile
11.1.4. Advantages & Disadvantages
11.1.5. Pipeline Development Activities
11.1.6. Product Profile
11.2. Drug D: Company 4
11.2.1. Drug Description
11.2.2. Clinical Trials Details
11.2.3. Safety and Efficacy Profile
11.2.4. Advantages & Disadvantages
11.2.5. Pipeline Development Activities
11.2.6. Product Profile
12. Narcolepsy Market Analysis 7MM
12.1. 7MM Market Size of Narcolepsy
12.2. 7MM Percentage Share of drugs marketed for Narcolepsy
12.3. 7MM Market Sales of Narcolepsy by Products
13. Narcolepsy Country-Wise Market Analysis
13.1. United States
13.1.1. Market Size of Narcolepsy in United States
13.1.2. Percentage Share of drugs marketed for Narcolepsy in United States
13.1.3. Market Sales of Narcolepsy by Products in United States
13.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2. EU-5
13.2.1. Germany
13.2.1.1. Market Size of Narcolepsy in Germany
13.2.1.2. Percentage Share of drugs marketed for Narcolepsy in Germany
13.2.1.3. Market Sales of Narcolepsy by Products in Germany
13.2.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.2. France
13.2.2.1. Market Size of Narcolepsy in France
13.2.2.2. Percentage Share of drugs marketed for Narcolepsy in France
13.2.2.3. Market Sales of Narcolepsy by Products in France
13.2.2.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.3. Italy
13.2.3.1. Market Size of Narcolepsy in Italy
13.2.3.2. Percentage Share of drugs marketed for Narcolepsy in Italy
13.2.3.3. Market Sales of Narcolepsy by Products in Italy
13.2.3.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.4. Spain
13.2.4.1. Market Size of Narcolepsy in Spain
13.2.4.2. Percentage Share of drugs marketed for Narcolepsy in Spain
13.2.4.3. Market Sales of Narcolepsy by Products in Spain
13.2.4.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.5. United Kingdom
13.2.5.1. Market Size of Narcolepsy in United Kingdom
13.2.5.2. Percentage Share of drugs marketed for Narcolepsy in United Kingdom
13.2.5.3. Market Sales of Narcolepsy by Products in United Kingdom
13.2.5.4. Analysis of Upcoming Therapies and their Impact on the Market
13.3. Japan
13.3.1. Market Size of Narcolepsy in Japan
13.3.2. Percentage Share of drugs marketed for Narcolepsy in Japan
13.3.3. Market Sales of Narcolepsy by Products in Japan
13.3.4. Analysis of Upcoming Therapies and their Impact on the Market
14. Market Drivers
15. Market Barriers
16. Appendix
17. Narcolepsy Report Methodology
17.1. Sources
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight

Tags
Close